Analysts Expect Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) to Post -$0.64 Earnings Per Share

Equities analysts expect that Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) will post earnings of ($0.64) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Iovance Biotherapeutics’ earnings, with the highest EPS estimate coming in at ($0.59) and the lowest estimate coming in at ($0.73). Iovance Biotherapeutics reported […]

Related Keywords

Wellington , New Zealand General , New Zealand , Blackrock , Thomson Reuter , Stifel Nicolaus , Iovance Biotherapeutic , Robertw Baird , Iovance Biotherapeutics , Zacks Investment Research , Perceptive Advisors , Wellington Management Group , Blackrock Inc , Nasdaq , Iovance Biotherapeutics Inc , Wells Fargo Company , Farallon Capital Management , Get Rating , Management Group , Capital Management , State Street Corp , Street Corp , Nasdaq Iova , Tiova , Medical , Ratings , Consensus ,